Science
It’s the first time the potential treatment, a small interfering RNA targeting the prion protein, is being tested in humans.
Administration
Former Artist-in-Residence Emilio Vavarella launches Lifeweave, a project developed during his Broad residency.
Community
In a #WhyIScience Q&A, Wolu Chukwu talks about how she brings a community-first focus to her work in cancer genetics.